Versor Investments LP Neogenomics Inc Transaction History

Versor Investments LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 30, 2023	BUY	$6.45 - $12.07 $130,309 - $243,850	20,203 Added 69.5%	49,270 $455,000
Q3 2022 Oct 25, 2022	BUY	$7.86 - $12.91 $228,466 - $375,254	29,067 New	29,067 $250,000
Q4 2021 Feb 08, 2022	SELL	$30.49 - $48.49 $237,578 - $377,834	-7,792 Closed	0 $0
Q3 2021 Nov 04, 2021	BUY	$41.66 - $52.52 $324,614 - $409,235	7,792 New	7,792 $376,000
Q4 2019 Feb 10, 2020	SELL	$18.96 - $29.84 $729,960 - $1.15 Million	-38,500 Closed	0 $0
Q3 2019 Nov 01, 2019	BUY	$19.12 - $26.24 $736,120 - $1.01 Million	38,500 New	38,500 $736,000

294

124M

698K

120K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $2.07B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Versor Investments LP, based on Form 13F filings with the SEC.

Stay updated on Versor Investments LP with notifications on news.